PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
130 hedge funds and large institutions have $571M invested in POINT Biopharma Global Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
90% less call options, than puts
Call options by funds: $70K | Put options by funds: $679K
Holders
130
Holding in Top 10
3
Calls
$70K
Puts
$679K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$8.71M | |
| 3 | +$7.85M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$6.08M |
| 5 |
JPMorgan Chase & Co
New York
|
+$5.27M |
Top Sellers
| 1 | -$22.2M | |
| 2 | -$17.3M | |
| 3 | -$10.7M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$6.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.64M |